Efficacy of genistein aglycone on some cardiovascular risk factors and homocysteine levels: A follow-up study

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 20, Issue 5, 2010, Pages 332-340

  Marini, H ^a   Bitto, A ^a   Altavilla, D ^a   Burnett, B P ^b   Polito, F ^a   Di Stefano, V ^a   Minutoli, L ^a   Atteritano, M ^a   Levy, R M ^b   Frisina, N ^a   Mazzaferro, S ^a   Frisina, A ^a   D'Anna, R ^a   Cancellieri, F ^a   Cannata, M L ^a   Corrado, F ^a   Lubrano, C ^c   Marini, R ^a   Adamo, E B ^a   Squadrito, F ^a  

^a UNIVERSITY OF MESSINA   (Italy)

^b PRIMUS PHARMACEUTICALS INC   (United States)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Cardiovascular risk; Genistein; Homocysteine; Menopause

Indexed keywords

CALCIUM CARBONATE; COLECALCIFEROL; GENISTEIN; HOMOCYSTEINE; LIPID; OSTEOPROTEGERIN;

ARTICLE; BLOOD; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; INSULIN RESISTANCE; METHODOLOGY; MIDDLE AGED; POSTMENOPAUSE; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR;

CALCIUM CARBONATE; CARDIOVASCULAR DISEASES; CHOLECALCIFEROL; FEMALE; FOLLOW-UP STUDIES; GENISTEIN; HOMOCYSTEINE; HUMANS; INSULIN RESISTANCE; LIPIDS; MIDDLE AGED; OSTEOPROTEGERIN; POSTMENOPAUSE; RESEARCH DESIGN; RISK FACTORS;

EID: 77955693086     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.numecd.2009.04.012     Document Type: Article

References (44)

1. Teede H.J. Sex hormones and the cardiovascular system: effects on arterial function in women. Clin Exp Pharmacol Physiol 2007, 34:672-676.
2. Rossouw J.E., Anderson G.L., Prentice R.L., LaCroix A.Z., Kooperberg C., Stefanick M.L., et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the women's health initiative randomized controlled trial. JAMA 2002, 288:321-333. Writing Group for the Women's Health Initiative Investigators.
3. Taggu W., Lloyd G. Treating cardiovascular disease in women. Menopause Int 2007, 13:159-164.
4. Adlercreutz H., Mazur W. Phyto-oestrogens and Western diseases. Ann Med 1997, 29:95-120.
5. Altavilla D., Crisafulli A., Marini H., Esposito M., D'Anna R., Corrado F., et al. Cardiovascular effects of the phytoestrogen genistein. Curr Med Chem Cardiovasc Hematol Agents 2004, 2:179-186.
6. Jackman K.A., Woodman O.L., Sobey C.G. Isoflavones, equol and cardiovascular disease: pharmacological and therapeutic insights. Curr Med Chem 2007, 14:2824-2830.
7. Si H., Liu D. Phytochemical genistein in the regulation of vascular function: new insights. Curr Med Chem 2007, 14:2581-2589.
8. Steensma A., Faassen-Peters M.A., Noteborn H.P., Rietjens I.M. Bioavailability of genistein and its glycoside genistin as measured in the portal vein of freely moving unanesthetized rats. J Agric Food Chem 2006, 54:8006-8012.
9. Setchell K.D., Brown N.M., Desai P., Zimmer-Nechemias L., Wolfe B.E., Brashear W.T. Bioavailability of pure isoflavones in healthy humans and analysis of commercial soy isoflavone supplements. J Nutr 2001, 131:1362S-1375S.
10. Kuiper G.G., Lemmen J.G., Carlsson B., Corton J.C., Safe S.H., van der Saag P.T., et al. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology 1988, 139:4252-4263.
11. Marini H., Minutoli L., Polito F., Bitto A., Altavilla D., Atteritano M., et al. Effects of the phytoestrogen genistein on bone metabolism in osteopenic postmenopausal women: a randomized trial. Ann Intern Med 2007, 146:839-847.
12. Squadrito F., Altavilla D., Morabito N., Crisafulli A., D'Anna R., Corrado F., et al. The effect of the phytoestrogen genistein on plasma nitric oxide concentrations, endothelin-1 levels and endothelium dependent vasodilation in postmenopausal women. Atherosclerosis 2002, 163:339-347.
13. D'Anna R., Cannata M.L., Atteritano M., Cancellieri F., Corrado F., Baviera G., et al. Effects of the phytoestrogen genistein on hot flushes, endometrium, and vaginal epithelium in postmenopausal women: a 1-year randomized, double-blind, placebo-controlled study. Menopause 2007, 14:648-655.
14. Atteritano M., Marini H., Minutoli L., Polito F., Bitto A., Altavilla D., et al. Effects of the phytoestrogen genistein on some predictors of cardiovascular risk in osteopenic, postmenopausal women: a two-year randomized, double-blind, placebo-controlled study. J Clin Endocrinol Metab 2007, 92:3068-3075.
15. Marini H., Bitto A., Altavilla D., Burnett B.P., Polito F., Di Stefano V., et al. Breast safety and efficacy of genistein aglycone for post-menopausal bone loss: a follow-up study. J Clin Endocrinol Metab 2008, 93:4787-4796.
16. McCarty M.F. Isoflavones made simple-genistein's agonist activity for the beta-type estrogen receptor mediates their health benefits. Med Hypotheses 2006, 66:1093-1114.
17. Setchell K.D. Phytoestrogens: the biochemistry, physiology, and implications for human health of soy isoflavones. Am J Clin Nutr 1998, 68:1333S-1346S.
18. Duffy C., Perez K., Partridge A. Implications of phytoestrogen intake for breast cancer. CA Cancer J Clin 2007, 57:260-277.
19. Cassidy A., Hooper L. Phytoestrogens and cardiovascular disease. J Br Menopause Soc 2006, 12:49-56.
20. Sacks F.M., Lichtenstein A., Van Horn L., Harris W., Kris-Etherton P., Winston M. Soy protein, isoflavones, and cardiovascular health: an American Heart Association Science Advisory for professionals from the Nutrition Committee. Circulation 2006, 113:1034-1044. American Heart Association Nutrition Committee.
21. Adlercreutz H., Wang G.J., Lapcik O., Hampl R., Wähälä K., Mäkelä T., et al. Time-resolved fluoroimmunoassay for plasma enterolactone. Anal Biochem 1998, 265:208-215.
22. Lee D.S., Lee S.H. Genistein, a soy isoflavone, is a potent alpha-glucosidase inhibitor. FEBS Lett 2001, 501:84-86.
23. Choi M.S., Jung U.J., Yeo J., Kim M.J., Lee M.K. Genistein and daidzein prevent diabetes onset by elevating insulin level and altering hepatic gluconeogenic and lipogenic enzyme activities in non-obese diabetic (NOD) mice. Diabetes Metab Res Rev 2008, 24:74-81.
24. Nakajima M., Cooney M.J., Tu A.H., Chang K.Y., Cao J., Ando A., et al. Normalization of retinal vascular permeability in experimental diabetes with genistein. Invest Ophthalmol Vis Sci 2001, 42:2110-2114.
25. Jayagopal V., Albertazzi P., Kilpatrick E.S., Howarth E.M., Jennings P.E., Hepburn D.A., et al. Beneficial effects of soy phytoestrogen intake in postmenopausal women with type 2 diabetes. Diabetes Care 2002, 25:1709-1714.
26. Hall W.L., Vafeiadou K., Hallund J., Bugel S., Reimann M., Koebnick C., et al. Soy-isoflavone-enriched foods and markers of lipid and glucose metabolism in postmenopausal women: interactions with genotype and equol production. Am J Clin Nutr 2006, 83:592-600.
27. Pittas A.G., Lau J., Hu F.B., Dawson-Hughes B. The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis. J Clin Endocrinol Metab 2007, 92:2017-2029.
28. Veloso R.V., Latorraca M.Q., Arantes V.C., Reis M.A., Ferreira F., Boschero A.C., et al. Soybean diet improves insulin secretion through activation of cAMP/PKA pathway in rats. J Nutr Biochem 2008, 19:778-784.
29. Wright D.C., Geiger P.C., Han D.H., Holloszy J.O. Are tyrosine kinases involved in mediating contraction-stimulated muscle glucose transport?. Am J Physiol Endocrinol Metab 2006, 290:E123-E128.
30. Dang Z.C., Audinot V., Papapoulos S.E., Boutin J.A., Löwik C.W. Peroxisome proliferator-activated receptor (PPAR) as a molecular target for the soy phytoestrogen genistein. J Biol Chem 2003, 278:962-967.
31. Zhan S., Ho S.C. Meta-analysis of the effects of soy protein containing isoflavones on the lipid profile. Am J Clin Nutr 2005, 81:397-408.
32. Jono S., Ikari Y., Shioi A., Mori K., Miki T., Hara K., et al. Serum osteoprotegerin levels are associated with the presence and severity of coronary artery disease. Circulation 2002, 106:1192-1194.
33. Min H., Morony S., Sarosi I., Dunstan C.R., Capparelli C., Scully S., et al. Osteoprotegerin reverses osteoporosis by inhibiting endosteal osteoclasts and prevents vascular calcification by blocking a process resembling osteoclastogenesis. J Exp Med 2000, 192:463-474.
34. Kannel W.B., Wolf P.A., Castelli W.P., D'Agostino R.B. Fibrinogen and the risk of cardiovascular disease: the Framingham Study. J Am Med Assoc 1987, 258:1183-1186.
35. Saadeddin S.M., Habbab M.A., Ferns G.A. Markers of inflammation and coronary artery disease. Med Sci Monit 2002, 8:5-12.
36. Rios D.R., Rodrigues E.T., Cardoso A.P., Montes M.B., Franceschini S.A., Toloi M.R. Effects of isoflavones on the coagulation and fibrinolytic system of postmenopausal women. Nutrition 2008, 24:120-126.
37. Madsen J.S., Kristensen S.R., Klitgaard N.A., Bladbjerg E.M., Abrahamsen B., Stilgren L., et al. Effect of long-term hormone replacement therapy on plasma homocysteine in postmenopausal women: a randomized controlled study. Am J Obstet Gynecol 2002, 187:33-39.
38. Hanson L.N., Engelman H.M., Alekel D.L., Schalinske K.L., Kohut M.L., Reddy M.B. Effects of soy isoflavones and phytate on homocysteine, C-reactive protein, and iron status in postmenopausal women. Am J Clin Nutr 2006, 84:774-780.
39. Reimann M., Dierkes J., Carlsohn A., Talbot D., Ferrari M., Hallund J., et al. Consumption of soy isoflavones does not affect plasma total homocysteine or asymmetric dimethylarginine concentrations in healthy postmenopausal women. J Nutr 2006, 136:100-105.
40. Helferich W.G., Andrade J.E., Hoagland M.S. Phytoestrogens and breast cancer: a complex story. Inflammopharmacology 2008, 16:219-226.
41. Unfer V., Casini M.L., Costabile L., Mignosa M., Gerli S., Di Renzo G.C. Endometrial effects of long-term treatment with phytoestrogens: a randomized, double-blind, placebo-controlled study. Fertil Steril 2004, 82:145-148.
42. Xu W.H., Zheng W., Xiang Y.B., Ruan Z.X., Cheng J.R., Dai Q., et al. Soya food intake and risk of endometrial cancer among Chinese women in Shanghai: population based case-control study. BMJ 2004, 328:1285.
43. Zeleniuch-Jacquotte A., Lundin E., Micheli A., Koenig K.L., Lenner P., Muti P., et al. Circulating enterolactone and risk of endometrial cancer. Int J Cancer 2006, 119:2376-2381.
44. Goodman M.T., Wilkens L.R., Hankin J.H., Lyu L.C., Wu A.H., Kolonel L.N. Association of soy and fiber consumption with the risk of endometrial cancer. Am J Epidemiol 1997, 146:294-306.